N,N-二甲基邻苯二胺 | 2836-03-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N,N-二甲基邻苯二胺
• 中文别名: 2-氨基-N,N-二甲基苯胺； N,N-二甲基邻苯二胺
• 英文名称: N,N-dimethyl-1,2-phenylenediamine
• 英文别名: N¹,N¹-dimethylbenzene-1,2-diamine；2-(N,N-dimethylamino)aniline；N,N-dimethyl-o-phenylenediamine；N,N-Dimethyl-o-phenylendiamin；2-Dimethylaminoanilin；N,N-dimethyl-1,2-benzenediamine；N,N-dimethylbenzene-1,2-diamine；2-Amino-N,N-dimethyl-anilin；2-amino-N,N-dimethylaniline；2-(dimethylamino)aniline；N1,N1-Dimethylbenzene-1,2-diamine；2-N,2-N-dimethylbenzene-1,2-diamine
• CAS: 2836-03-5
• 化学式: C₈H₁₂N₂
• mdl: MFCD01706706
• 分子量: 136.197
• InChiKey: HJXIRCMNJLIHQR-UHFFFAOYSA-N

物化性质

• 沸点：
  240.49°C (rough estimate)
• 密度：
  1.049
• 保留指数：
  1216

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  29.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2921590090
• 包装等级：
  III
• 危险类别：
  9
• 危险性防范说明：
  P501,P273,P272,P260,P270,P202,P201,P271,P264,P280,P391,P308+P311,P361+P364,P333+P313,P301+P312+P330,P302+P352+P312,P304+P340+P311,P305+P351+P338+P310,P403+P233,P405
• 危险品运输编号：
  3082
• 危险性描述：
  H311+H331,H302,H318,H361,H373,H317
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-N,N-dimethylaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-N,N-dimethylaniline
CAS number: 2836-03-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H12N2
Molecular weight: 136.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N,N-二甲基邻苯二胺 在 potassium dichromate 、 aluminum(III) sulphate octadecahydrate 、 sodium thiosulfate 、 zinc(II) chloride 作用下， 以 水 为溶剂， 反应 2.5h， 以46%的产率得到2-amino-5-dimethylaminophenylthiosulphonic acid
  参考文献：
  名称：

  一种钙敏感受体蛋白拮抗剂衍生的分子探针及在甲状旁腺切除手术中的应用

  摘要：

  本发明公开了一种钙敏感受体蛋白拮抗剂衍生的分子探针及在甲状旁腺切除手术中的应用。具体为手性钙敏蛋白抑制剂拮抗剂Calhex 231衍生的含有如通式A1所示的荧光基团的分子探针或含有如通式A2所示的生色团的分子探针；所述通式A1和通式A2的结构如下所示：或者

  公开号：

  CN113173891A
• 作为产物：
  描述：

  N,N-二甲基对硝基苯胺 在 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、405.33 kPa 条件下， 反应 4.0h， 生成 N,N-二甲基邻苯二胺
  参考文献：
  名称：

  Synthesis of benzimidazoles via iridium-catalyzed acceptorless dehydrogenative coupling

  摘要：

  苯并咪唑类化合物通过铱催化的受体无氧脱氢偶联反应，产率较高。

  DOI：

  10.1039/c5ob00904a
• 作为试剂：
  描述：

  [4-(2,5-dichloro-phenoxy)-pyridin-3-yl]-(3,4-dihydro-2H-quinolin-1-yl)-methanone 、 N,N-二甲基邻苯二胺 在 N,N-二甲基邻苯二胺 作用下， 生成 4-(2,5-dichloro-phenoxy)-N-(2-dimethylamino-phenyl)-nicotinamide
  参考文献：
  名称：

  4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds

  摘要：

  本发明涉及以下式子的新型苯酰胺或吡啶酰胺衍生物： 其中A1、A2、B1、B2和R1到R11如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物是GPBAR1激动剂，可用作治疗二型糖尿病等疾病的药物。

  公开号：

  US08420647B2

文献信息

• [EN] 4-PHENOXY-NICOTINAMIDE OR 4-PHENOXY-PYRIMIDINE-5-CARBOXAMIDE COMPOUNDS<br/>[FR] COMPOSÉS DE 4-PHÉNOXYNICOTINAMIDE OU DE 4-PHÉNOXY-PYRIMIDINE-5-CARBOXAMIDE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011089099A1

  公开（公告）日：2011-07-28

  This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula (I), wherein A1, A2, B1, B2 and R1 to R11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

  这项发明涉及公式（I）中的新型苯基酰胺或吡啶基酰胺衍生物，其中A1、A2、B1、B2和R1至R11如描述和索赔中所定义，并且其药学上可接受的盐。这些化合物是GPBAR1激动剂，可用作治疗疾病如2型糖尿病的药物。
• Transition-Metal-Free Access to Primary Anilines from Boronic Acids and a Common ⁺NH₂ Equivalent.
  作者：Samantha Voth、Joshua W. Hollett、J. Adam McCubbin

  DOI：10.1021/jo5025078

  日期：2015.3.6

  are obtained at refluxing temperatures. Our method is also amenable to electrophilic amination of several common boronic acid derivatives (e.g., pinacol esters). We demonstrate that it can be combined with metal–halogen exchange reactions or a variety of directed ortho metalation protocols in a “one-pot” sequence for the synthesis of aromatic amines with unique substitution patterns. DFT studies, in

  通过使用常见的廉价亲电氮源（H 2 N-OSO 3H，HSA）。通过这种方法发现富含电子的底物具有最高的反应性。但是，在室温条件下，即使是中等电子贫乏的基材也能很好地耐受。与不受阻碍的基材相比，受阻的基材似乎同样有效。高度缺乏电子的底物在室温下以非常低的产率提供产物，但是在回流温度下获得中等至良好的产率。我们的方法也适用于几种常见的硼酸衍生物（例如频哪醇酯）的亲电胺化反应。我们证明了它可以与金属-卤素交换反应或各种定向的邻位金属化方案以“一锅”顺序结合使用，以合成具有独特取代模式的芳香胺。DFT研究，结合实验结果，表明该反应是通过碱介导的HSA活化发生的，然后发生1,2芳基B–N迁移。这种活化方式对于反应的成功似乎至关重要，并且首次允许在环境温度下对硼酸进行一般的亲电子胺化。
• Visible-Light-Induced Nickel-Catalyzed Cross-Coupling with Alkylzirconocenes from Unactivated Alkenes
  作者：Yadong Gao、Chao Yang、Songlin Bai、Xiaolei Liu、Qingcui Wu、Jing Wang、Chao Jiang、Xiangbing Qi

  DOI：10.1016/j.chempr.2019.12.010

  日期：2020.3

  Transition-metal-catalyzed cross-coupling reactions between naturally abundant sp3-hybridized carbon centers facilitate access to diverse molecules with complex three-dimensional structures. Organometallic compounds are among one of the most powerful reagents that are broadly used in carbon–carbon bond formations. Although sp2-hybridized organometallic compounds are widely employed in cross-couplings, sp3-hybridized

  自然丰富的sp 3-杂化碳中心之间的过渡金属催化交叉偶联反应有助于获得具有复杂三维结构的各种分子。有机金属化合物是最强大的试剂之一，广泛用于碳-碳键的形成。尽管sp 2-杂化的有机金属化合物广泛用于交叉偶联，但是sp 3-杂化的有机金属偶联剂的开发较少。在这里，我们报告可见光诱导的单个镍催化的C（sp 3）–C（sp 3），C（sp 3）–C（sp 2）和C（sp 3）–C（sp）使用烷基锆茂的交叉偶联反应，该反应很容易从末端或内部未活化的烯烃通过加氢锆和链步反应就地生成。该方法温和，适用于多种底物，包括伯，仲，叔烷基，芳基，烯基，炔基卤化物和各种烯烃。机理研究表明，镍催化的自由基交叉偶联是一种新颖的途径，代表了锆锆茂的首次可见光诱导的转变。
• [EN] BRUTON'S TYROSINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE TYROSINE KINASE DE BRUTON
  申请人：BIOGEN IDEC INC

  公开号：WO2011029046A1

  公开（公告）日：2011-03-10

  The present invention provides compounds useful as inhibitors of Btk, compositions thereof, and methods of using the same.

  本发明提供了用作Btk抑制剂的化合物、其组合物以及使用方法。
• A new facile, efficient synthesis and structure peculiarity of quinoxaline derivatives with two benzimidazole fragments
  作者：Vakhid A. Mamedov、Nataliya A. Zhukova、Victor V. Syakaev、Aidar T. Gubaidullin、Tat'yana N. Beschastnova、Dil'bar I. Adgamova、Aida I. Samigullina、Shamil K. Latypov

  DOI：10.1016/j.tet.2012.10.045

  日期：2013.1

  A highly efficient and versatile method for the synthesis of quinoxaline derivatives with two benzimidazole fragments have been developed on the basis of the ring contraction of 3-(benzimidazo-2-yl)quinoxalin-2(1H)-one with 1,2-diaminobenzene and its various types of substituted and condensed derivatives. Owing to the inter- and intramolecular processes, involving self association, proton exchange

  基于3-（苯并咪唑-2-基）喹喔啉-2（1 H）-与1,2-的环收缩，已开发出一种高效且通用的具有两个苯并咪唑片段的喹喔啉衍生物的合成方法。二氨基苯及其各种类型的取代和稠合衍生物。由于分子间和分子内过程，涉及桥联和相邻碳原子的大多数双-苯并咪唑基喹喔啉信号的几种形式之间的自缔合，质子交换，构象和/或互变异构交换，且NMR光谱中的苯并咪唑片段变宽。苯并咪唑片段与分子的喹喔啉核心之间的共轭作用比喹喔啉衍生物（10c）与其噻二唑[ f ]-（17）和吡咯并[ a ]-（19）环化了衍生物，导致整个分子的平面度更大。

表征谱图